Immunotherapy in sepsis - brake or accelerate?
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference288 articles.
1. Caspase-11 protects against bacteria that escape the vacuole;Aachoui;Science,2013
2. cGAS in action: Expanding roles in immunity and inflammation;Ablasser;Science,2019
3. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group;Abraham;Lancet,1998
4. p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group;Abraham;JAMA,1997
5. Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial;Abraham;JAMA,2003
Cited by 84 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Into the storm: the imbalance in the yin-yang immune response as the commonality of cytokine storm syndromes;Frontiers in Immunology;2024-09-10
2. Evolving Paradigms in Sepsis Management: A Narrative Review;Cells;2024-07-09
3. Tofacitinib Treatment Suppresses CD4+ T-Cell Activation and Th1 Response, Contributing to Protection against Staphylococcal Toxic Shock;International Journal of Molecular Sciences;2024-07-07
4. Protective effects of Wenqingyin on sepsis-induced acute lung injury through regulation of the receptor for advanced glycation end products pathway;Phytomedicine;2024-07
5. Towards personalized medicine: a scoping review of immunotherapy in sepsis;Critical Care;2024-05-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3